Metraipolis › archive › dc_ff13ee75c7b8
Antibody-functionalized lipid nanocarriers for RNA-based cancer gene therapy: advances and challenges in targeted delivery — Europe PMC PMID:40880603
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40880603
- DOI
- 10.1039/d5na00323g
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:27:36.625Z
- SHA-256 of the archived text
fca4e2980fcc49b087f5ca52ccffe698e281e771c7f841d980f5336933f2164f- Stable URL of this page
https://metraipolis.com/documento/dc_ff13ee75c7b8
How to cite
Antibody-functionalized lipid nanocarriers for RNA-based cancer gene therapy: advances and challenges in targeted delivery — Europe PMC PMID:40880603 — Europe PMC (en), https://europepmc.org/article/MED/40880603 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff13ee75c7b8 (Metraipolis archive dc_ff13ee75c7b8, sha256 fca4e2980fcc49b087f5ca52ccffe698e281e771c7f841d980f5336933f2164f)
BibTeX
@misc{dcff13ee75c7b8,
title = {Antibody-functionalized lipid nanocarriers for RNA-based cancer gene therapy: advances and challenges in targeted delivery — Europe PMC PMID:40880603},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40880603},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff13ee75c7b8; sha256 fca4e2980fcc49b087f5ca52ccffe698e281e771c7f841d980f5336933f2164f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40880603. Agents can read the archived copy with the MCP tool read_document.